Nan Fung Group Holdings’s Bolt Biotherapeutics BOLT Stock Holding History

Nan Fung Group Holdings’s Portfolio BOLT Stock Details BOLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.3K	Sell	5,000 -24,250	-83%	-$114K	0.01%	25
2026 Q1	$118K	Sell	29,250 -29,097	-50%	-$152K	0.1%	24
2025 Q4	$319K	Hold	58,347	–	–	0.29%	25
2025 Q3	$310K	Hold	58,347	–	–	0.52%	20
2025 Q2	$337K	Sell	58,347 -1	-0%	-$7	0.53%	17
2025 Q1	$467K	Hold	58,348	–	–	0.38%	30
2024 Q4	$624K	Hold	58,348	–	–	0.53%	30
2024 Q3	$756K	Hold	58,348	–	–	0.65%	27
2024 Q2	$875K	Hold	58,348	–	–	0.93%	24
2024 Q1	$1.63M	Hold	58,348	–	–	1.51%	19
2023 Q4	$1.31M	Hold	58,348	–	–	0.81%	20
2023 Q3	$1.21M	Hold	58,348	–	–	0.98%	17
2023 Q2	$1.49M	Hold	58,348	–	–	0.95%	19
2023 Q1	$1.62M	Hold	58,348	–	–	1.1%	17
2022 Q4	$1.52M	Hold	58,348	–	–	1.05%	15
2022 Q3	$1.73M	Hold	58,348	–	–	1.1%	16
2022 Q2	$2.38M	Hold	58,348	–	–	1.64%	12
2022 Q1	$3.2M	Hold	58,348	–	–	1.52%	11
2021 Q4	$5.72M	Hold	58,348	–	–	1.69%	12
2021 Q3	$14.8M	Hold	58,348	–	–	4.73%	7
2021 Q2	$18M	Buy	+58,348	New	+$23.7M	5.61%	5

Other funds holding BOLT

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

T3 Companies New York $93.7M AUM

BOTOTLSJU

Board of Trustees of The Leland Stanford Junior University Redwood City, California $533M AUM 65.58% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

NCNMGF

Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nan Fung Group Holdings's BOLT Position: Q2 2026 in Review

Nan Fung Group Holdings reduced its Bolt Biotherapeutics (BOLT) stake by 83% in Q2 2026, selling an estimated $114K and leaving 5,000 shares worth $19.3K. The position accounts for 0.01% of the portfolio, ranked #25.

Nan Fung Group Holdings first reported a position in BOLT in Q2 2021 and has held it in 21 quarters since. The position peaked at $18M in Q2 2021. 23 funds tracked by Wall St. Rank hold BOLT as of Q2 2026.

Nan Fung Group Holdings held 5,000 shares of Bolt Biotherapeutics worth $19.3K as of Q2 2026.
Nan Fung Group Holdings sold 24,250 Bolt Biotherapeutics shares in Q2 2026, an estimated $114K.
Bolt Biotherapeutics made up 0.01% of Nan Fung Group Holdings's portfolio in Q2 2026, its #25 holding.
Nan Fung Group Holdings first reported a position in Bolt Biotherapeutics in Q2 2021 and has held it in 21 quarters since.
Nan Fung Group Holdings's Bolt Biotherapeutics position peaked at $18M in Q2 2021.
23 funds tracked by Wall St. Rank held Bolt Biotherapeutics as of Q2 2026.

Based on Nan Fung Group Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.